Marijuana-based prescription drug looks toward FDA's approval

U.K.-based GW Pharma is in advanced clinical trials for the world's first pharmaceutical developed from raw marijuana — a mouth spray it hopes to market in the U.S. as a treatment for cancer pain
The Associated Press
Sunday, January 22, 2012

A quarter-century after the U.S. Food and Drug Administration approved the first prescription drugs based on the main psychoactive ingredient in marijuana, additional medicines derived from or inspired by the cannabis plant itself could soon be making their way to pharmacy shelves, according to drug companies, small biotech firms and university scientists.